Ironwood Pharmaceuticals (IRWD) Amortization - Intangibles (2016 - 2018)

Ironwood Pharmaceuticals has disclosed Amortization - Intangibles across 3 years of filings, most recently posting $1.2 million for Q3 2018.

• In Q3 2018, Amortization - Intangibles fell 38.9% year-over-year to $1.2 million; the TTM figure through Dec 2018 stood at $8.1 million (up 30.53% YoY), while the FY2018 annual figure was $8.1 million, up 30.53% from the prior year.
• Amortization - Intangibles came in at $1.2 million for Q3 2018 at Ironwood Pharmaceuticals, down from $3.5 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $3.5 million in Q4 2017 to a low of $420000.0 in Q1 2017.
• Average Amortization - Intangibles over 3 years is $2.2 million, with a median of $2.5 million recorded in 2016.
• Year-over-year, Amortization - Intangibles sank 60.47% in 2017 and surged 727.62% in 2018.
• Over 3 years, Amortization - Intangibles stood at $3.3 million in 2016, then climbed by 5.33% to $3.5 million in 2017, then plunged by 66.66% to $1.2 million in 2018.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $1.2 million in Q3 2018, $3.5 million in Q2 2018, and $3.5 million in Q1 2018.